Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

CytoAgents’ Phase 1 Trial Results Show “Cytokine Release Syndrome” Drug Candidate Safe,

The safety data presented in the final clinical study report supports further human clinical development of GP1681 used to treat the excessive …, The safety data presented in the final clinical study report supports further human clinical development of GP1681 used to treat the excessive …, Read More

Scroll to Top